Markets.com Logo

BDTX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2.5923$
  • Previous Close
    2.6836$
  • 52 Week Change
    5.47$
  • Day Range
    -0.09$
  • 52 Week High/Low
    1.195$ - 6.66$
  • Dividend Per Share
    --
  • Market cap
    148 M$
  • EPS
    -0.19
  • Beta
    2.876
  • Volume
    --

About

BDTX.US represents Black Diamond Therapeutics, Inc., a precision oncology medicine company dedicated to unlocking the potential of MasterKey therapies. These therapies are designed to target driver mutations in patients with genetically defined cancers. Black Diamond Therapeutics is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol BDTX. They focus on developing therapies that selectively target oncogenic mutations of the MAPK signaling pathway, aiming to provide more effective and personalized treatments for cancer patients.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Company Performance: Revenue, earnings, and profitability directly influence investor confidence and stock value.

Industry Trends: Overall health and growth prospects of the biotech sector, including regulatory changes and market competition, affect BDTX.US.

Clinical Trial Results: Positive or negative outcomes from clinical trials for BDTX's drug candidates are major price drivers.

Regulatory Approvals: FDA decisions on BDTX's products significantly impact market access and revenue potential.

Partnerships & Acquisitions: Strategic alliances, licensing agreements, or potential acquisitions can alter investor perceptions.

Market Sentiment: General investor mood and risk appetite regarding biotech stocks and smaller-cap companies influence demand.

Economic Conditions: Broader economic factors like interest rates, inflation, and recessionary fears can impact investment decisions.

Competition: Activities of rival companies and the emergence of competing therapies can affect BDTX's market share.

Management Decisions: Strategic decisions made by BDTX's leadership team concerning research, development, and marketing influence investor views.

News & Events: Company-specific news releases, industry conferences, and global events can trigger price volatility.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--